Topiramate Tablet, Film Coated
Product Images NDC 68788-4067
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68788-4067). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)
This text shows a comparison of cumulative rates for time to the first seizure between two groups receiving different dosages of Topiramate. The time to the first seizure is plotted on the X-axis (Time in Days), while the cumulative rates are plotted on the Y-axis. Group 1 received 50 mg/day (N=234), and Group 2 received 400 mg/day (N=236) of Topiramate. The p-value for the comparison between the two groups is 0.00002, indicating a statistically significant difference.*
Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)
Topiramate Tab Usp 200mg (9df497de Be9f 4244 A769 A72a0e64dc42 06)
This is a description of a medication called Topiramate Tab USP 200mg (Generic for Topamax). It is in film-coated tablet form and is used to treat certain conditions. The tablets are yellow and round with markings on them. The medication should be stored at a temperature of 20° to 25°C (68° to 77°F) and protected from moisture. It is important to keep this medication out of the reach of children, and it should only be used as prescribed by a healthcare professional.*
Image (B609e53c 2d69 4437 B2a1 9f322208eb27 565 2)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.